✦ LIBER ✦

Acceptability of a new modular protein substitute for the dietary treatment of phenylketonuria

✍ Scribed by F.J. Rohr; A.W. Munier; H.L. Levy

Book ID: 110316314
Publisher: Springer
Year: 2001
Tongue: English
Weight: 66 KB
Volume: 24
Category: Article
ISSN: 0141-8955
DOI: 10.1023/a:1012754724708

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effectiveness of Dietary Treatment in Ph

Effectiveness of Dietary Treatment in Phenylketonuria: What is the Proof?

✍ Phyllis W. Herman; Harry A. Waisman; Frances K. Graham. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 506 KB

The use of gelatin capsules for ingestio

The use of gelatin capsules for ingestion of formula in dietary treatment of maternal phenylketonuria

✍ H. H. Kecskemethy; D. Lobbregt; H. L. Levy 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 718 KB

Is Melatonin Synthesis a New Biomarker f

Is Melatonin Synthesis a New Biomarker for the Pathogenesis and Treatment of Phenylketonuria?

✍ Cederbaum, Stephen; Levy, Harvey L. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Hypophenate, a Soviet drug for the treat

Hypophenate, a Soviet drug for the treatment of phenylketonuria

✍ M. V. Podol'skii; L. V. Zakharova; Z. V. Gol'tseva; é. D. Glinka; B. V. Lebedev 📂 Article 📅 1970 🏛 Springer 🌐 English ⚖ 215 KB

Use of the Guthrie bacterial inhibition

Use of the Guthrie bacterial inhibition assay to monitor blood phenylalanine for dietary treatment of phenylketonuria

✍ Frances J. Rohr; Elizabeth N. Allred; Melissa Turner; Jane Simmons; Harvey L. Le 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 459 KB

Decreased vigilance and neurotransmitter

Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment for phenylketonuria in adolescents

✍ H. C. Lou; F. Güttler; C. Lykkelund; P. Bruhn; A. Niederwieser 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 337 KB

Four adolescent or young adult patients with phenylketonuria were examined before and after discontinuation of dietary treatment. Plasma and CSF phenylalanine concentrations increased about two-fold in three patients. In these patients the CSF concentration of the dopamine and serotonin metabolites